Schonfeld Strategic Advisors’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-27,735
| Closed | -$1.09M | – | 2383 |
|
|
2025
Q1 | $1.09M | Buy |
+27,735
| New | +$1.09M | 0.01% | 1135 |
|
|
2024
Q4 | – | Sell |
-198,613
| Closed | -$4.65M | – | 2232 |
|
|
2024
Q3 | $4.65M | Sell |
198,613
-71,671
| -27% | -$1.68M | 0.03% | 471 |
|
|
2024
Q2 | $4.81M | Sell |
270,284
-220,814
| -45% | -$3.93M | 0.03% | 485 |
|
|
2024
Q1 | $7.47M | Buy |
491,098
+153,949
| +46% | +$2.34M | 0.05% | 413 |
|
|
2023
Q4 | $5.76M | Sell |
337,149
-1,030,251
| -75% | -$17.6M | 0.04% | 443 |
|
|
2023
Q3 | $11.4M | Buy |
1,367,400
+850,507
| +165% | +$7.11M | 0.09% | 278 |
|
|
2023
Q2 | $12.8M | Sell |
516,893
-548,320
| -51% | -$13.6M | 0.11% | 287 |
|
|
2023
Q1 | $16M | Buy |
1,065,213
+1,002,213
| +1,591% | +$15.1M | 0.15% | 189 |
|
|
2022
Q4 | $745K | Buy |
63,000
+23,652
| +60% | +$280K | 0.01% | 1304 |
|
|
2022
Q3 | $233K | Sell |
39,348
-396,983
| -91% | -$2.35M | ﹤0.01% | 2207 |
|
|
2022
Q2 | $1.85M | Buy |
+436,331
| New | +$1.85M | 0.02% | 712 |
|
|
2021
Q1 | – | Sell |
-23,537
| Closed | -$1.22M | – | 2058 |
|
|
2020
Q4 | $1.22M | Buy |
+23,537
| New | +$1.22M | 0.02% | 711 |
|
|
2020
Q3 | – | Sell |
-44,479
| Closed | -$867K | – | 1596 |
|
|
2020
Q2 | $867K | Buy |
44,479
+23,261
| +110% | +$453K | 0.02% | 603 |
|
|
2020
Q1 | $209K | Buy |
+21,218
| New | +$209K | 0.01% | 901 |
|
|
2018
Q2 | – | Sell |
-33,277
| Closed | -$472K | – | 953 |
|
|
2018
Q1 | $472K | Buy |
+33,277
| New | +$472K | 0.04% | 491 |
|